中年の医療費と医療利用は,併発性疾患,機能的制限,人種/民族の交差点にある
Mohammad Usama Toseef1,2, Shanmin Sultana3, Preethy Samuel3
1Corewell Health Research Institute, Royal Oak, Michigan, United States.
Innovation in aging
|February 20, 2026
まとめ
複雑な慢性疾患を持つ中年の成人は,より高い医療費に直面しています. 人種・民族・機能的制約は,医療サービスの利用と支出パターンに著しく影響し,標的を絞った介入の必要性を強調しています.
科学分野:
- 医療サービス 研究 医療サービス
- 慢性疾患管理について
- 健康の格差について
背景:
- 中年期は,慢性疾患や機能的限界が現れ,健康への移行にとって重要な人生の段階です.
- 人種/民族などの社会的決定要因は,併発性および機能的制限の影響を悪化させる可能性があります.
- これらの要因を理解することは,中年の成人の健康の軌道を決定的に重要です.
研究 の 目的:
- 併発症,機能的制限,人種/民族が,中年成人の医療サービス利用と支出にどのように影響するか検討する.
- これらの要因に基づいて,医療利用と支出における格差を特定する.
- 脆弱な集団のためのターゲット化されたヘルスケア戦略を伝えるために.
主な方法:
- 50~64歳の成人の医療費パネル調査 (2008年~2022年,2020年を除く) の総合的横断データ.
- 併発性現象型を特定するための潜在クラス分析 (LCA).
- 一般化された線形回帰は,機能的制限と人種/民族をコントロールして,医療サービス成果との関連を評価する.
主要な成果:
- 3つの併発症クラスが特定されました:低罹患率 (63.4%),高血圧/関節炎/関節痛 (29.3%),および複雑な心血管 (C-CVD, 7.3%).
- C-CVD患者は,より多くのオフィスベースの訪問 (OBV) にかかわらず,緊急治療室 (ED) と入院患者入院を含む,より高い医療支出と使用を示しました.
- 非ヒスパニック系黒人 (NHB) とヒスパニック系成人は,非ヒスパニック系白人 (NHW) の成人に比べて支出とOBVの使用量が低い. NHBはEDの使用率が高く,ヒスパニックは入院率が低い. 機能的制限は,人種/民族のグループ全体でOBVと入院パターンに影響を与えました.
結論:
- 標的を絞った医療介入は,特に複雑な慢性疾患を有する高リスク集団にとって不可欠です.
- 医療へのアクセスと利用における人種/民族および機能的制限に関連する格差に対処することは極めて重要です.
- 併発性,人種/民族,機能的状態を考慮したパーソナライズされたケア戦略は,健康上の負担を軽減することができます.
関連する概念動画
Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Dimensions of Health and Illness
The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
Factors Affecting Illness
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
For instance, risk factors are connected to illness, disability,...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


